A Clinical Study of Masoor Ksheerpista Lepa in the Management of Vyanga
International Journal of Drug Delivery Technology · 29.06.2026 · 16 (59s)
DOI: 10.25258/ijddt.16.59s.55 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.06.2026. Verfasst von Harish Sharan Sahu und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Vyanga is a non-communicable pigmentary disorder predominantly affecting the facial region. It is described in Ayurveda under the category of Kshudra Roga and is primarily associated with the vitiation of Vata and Pitta Doshas along with Rakta Dushti. In modern medicine, Melasma is considered a complex dermatological condition influenced by factors such as hormonal imbalance, pregnancy, ultraviolet (UV) radiation exposure and psychological factors. The condition adversely affects cosmetic appearance and self-confidence.
Aim
To Study the Clinical Effect of Masoor Ksheerpista Lepa in Vyanga Materials and Methods: A total of 40 registered patients of Vyanga were divided into two groups. Group A was treated with Masoor Jala Lepa and Group B was treated with Masoor Ksheerpista Lepa, applied once daily for a period of two months as part of the treatment regimen. The assessment was conducted based on clinical symptoms and statistical analysis. All participants in both groups were instructed to adhere to the Nidana–Parihara regimen and follow a daily routine throughout the study period.
Results
Treatment Outcomes after 2 Months: Group A - 4 patients (20%) showed moderate improvement, 8 patients (40%) showed mild improvement and 8 patients (40%) remained unchanged. Group B - 10 patients (50%) showed marked improvement, 9 patients (45%) showed moderate improvement, and 1 patient (5%) showed mild improvement.
Conclusion
Both Masoor Ksheerpista Lepa and Masoor Jala Lepa were found to be effective; however, Masoor Ksheerpista Lepa demonstrated superior efficacy in reducing Rukshata, Shyava Varna, Snigdhata and Mandala Swaroopa. The findings of this study indicate that adherence to the daily regimen and Nidana-Parihara plays a significant role in preventing both the manifestation and progression of Vyanga. Therefore, the Null Hypothesis is rejected and the Alternate Hypothesis is accepted.
Zitieren
APA
Sahu, H. S., Sahu, N., Jangde, S., Sahu, C., Hrabansh, P. K., Taram, G., & Binjhwar, D. (2026). A Clinical Study of Masoor Ksheerpista Lepa in the Management of Vyanga. International Journal of Drug Delivery Technology, 16(59s). https://doi.org/10.25258/ijddt.16.59s.55
Vancouver
Sahu HS, Sahu N, Jangde S, Sahu C, Hrabansh PK, Taram G, et al. A Clinical Study of Masoor Ksheerpista Lepa in the Management of Vyanga. International Journal of Drug Delivery Technology. 2026;16(59s). doi:10.25258/ijddt.16.59s.55
BibTeX
@article{Sahu2026,
author = {Sahu, Harish Sharan and Sahu, Neha and Jangde, Swaranjali and Sahu, Champa and Hrabansh, Praveen Kumar and Taram, Gamini and Binjhwar, Dharmendra},
title = {A Clinical Study of Masoor Ksheerpista Lepa in the Management of Vyanga},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {59s},
doi = {10.25258/ijddt.16.59s.55}
}
EUVIMED